Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis
► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 403; no. 1; pp. 103 - 107 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
03.12.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | ► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene.
While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. |
---|---|
AbstractList | While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers.
In vitro
studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis
in vivo
. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/
neu
mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. ► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ► Akt-activated p21 promoted lung metastasis in MMTV/neu mice. ► In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis.While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. a-[ordm Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. a-[ordm Akt-activated p21 accelerated tumor onset in MMTV/neu mice. a-[ordm Akt-activated p21 promoted lung metastasis in MMTV/neu mice. a-[ordm In vivo evidence that cytoplasmic p21 functions as an oncogene. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of human cancers. In vitro studies showed that the oncogenic function of p21is closely related to its cytoplasmic localization. However, it is unclear whether cytoplasmic p21 contributes to tumorigenesis in vivo. To address this question, we generated transgenic mice expressing the Akt-phosphorylated form of p21 (p21T145D) in the mammary epithelium. The results showed that Akt-activated p21 was expressed in the cytoplasm of mammary epithelium. Overexpression of Akt-activated p21 accelerated tumor onset and promoted lung metastasis in MMTV/neu mice, providing evidence that p21, especially cytoplasmic phosphorylated p21, has an oncogenic role in promoting mammary tumorigenesis and metastasis. |
Author | Hsu, Jennifer L. Hung, Mien-Chie Cheng, Xiaoyun Sun, Hui-Lung Xia, Weiya Chou, Chao-Kai Muller, William J. Wyszomierski, Shannon L. Yang, Jer-Yen Mills, Gordon B. Yu, Dihua |
AuthorAffiliation | 2 Departments of System Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA 5 Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical and University Hospital, Taichung 404, Taiwan 1 Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA 4 Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, H3A1A1, Canada 3 Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas 77030, USA |
AuthorAffiliation_xml | – name: 1 Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA – name: 5 Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical and University Hospital, Taichung 404, Taiwan – name: 4 Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, H3A1A1, Canada – name: 2 Departments of System Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA – name: 3 Graduate School of Biomedical Sciences, The University of Texas, Houston, Texas 77030, USA |
Author_xml | – sequence: 1 givenname: Xiaoyun surname: Cheng fullname: Cheng, Xiaoyun organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 2 givenname: Weiya surname: Xia fullname: Xia, Weiya organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 3 givenname: Jer-Yen surname: Yang fullname: Yang, Jer-Yen organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 4 givenname: Jennifer L. surname: Hsu fullname: Hsu, Jennifer L. organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 5 givenname: Chao-Kai surname: Chou fullname: Chou, Chao-Kai organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 6 givenname: Hui-Lung surname: Sun fullname: Sun, Hui-Lung organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 7 givenname: Shannon L. surname: Wyszomierski fullname: Wyszomierski, Shannon L. organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 8 givenname: Gordon B. surname: Mills fullname: Mills, Gordon B. organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 9 givenname: William J. surname: Muller fullname: Muller, William J. organization: Department of Medicine and Biochemistry, McGill University, Montreal, Quebec, Canada H3A1A1 – sequence: 10 givenname: Dihua surname: Yu fullname: Yu, Dihua organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA – sequence: 11 givenname: Mien-Chie surname: Hung fullname: Hung, Mien-Chie email: mhung@mdanderson.org organization: Department of Molecular and Cellular Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21040707$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkVFrFDEUhYNU7Lb6B3yQvKkPs00yM9kZkMKyWC0U9EHRt5C5c7PNMpNMk8yC_96Z3baoDxUCgXvPOZzkOyMnzjsk5DVnS864vNgtmybAUrDDYMmFfEYWnNUsE5wVJ2TBGJOZqPnPU3IW444xzgtZvyCn856t2GpB7taQ7F4n6x31hg6Cv9tcf-UXP9ZX_D21jva673X4RXGw6RY7O_ZUA2CHQSeMj-s09j7YLTqMNlLtWjoE3_tZ0o1uS3tMOk7HxpfkudFdxFf39zn5fvXx2-ZzdvPl0_VmfZNByaqU6SYvRV4BGoAmR4ZYotYCDHCDxhStYQWUAFUroAAhTZ2LomlWgkOFRpr8nFwec4ex6bEFdCnoTg3BzoWV11b9vXH2Vm39XuXTPwmRTwFv7wOCvxsxJtXbOL280w79GFXNVrwshaz-q6y4zCvJhJyUb_4s9djmAcgkqI4CCD7GgEaBTQc8U0fbKc7UzF7t1MxezewPs0O2-Mf6kP6k6cPRhBOKvcWgIlh0gK0NCEm13j5l_w2I3ctM |
CitedBy_id | crossref_primary_10_1016_j_steroids_2012_11_003 crossref_primary_10_18632_aging_202519 crossref_primary_10_1007_s12282_018_0913_1 crossref_primary_10_3233_CBM_160308 crossref_primary_10_3748_wjg_v21_i42_12150 crossref_primary_10_1097_SPC_0b013e328350f70c crossref_primary_10_1186_s13058_017_0853_2 crossref_primary_10_1080_15384101_2023_2249702 crossref_primary_10_1111_bph_13045 crossref_primary_10_1016_j_biochi_2011_04_019 crossref_primary_10_1007_s00535_013_0900_4 crossref_primary_10_1186_s12885_015_1895_4 crossref_primary_10_2478_sjecr_2023_0005 crossref_primary_10_1242_jcs_089110 crossref_primary_10_18632_oncotarget_2844 crossref_primary_10_1093_jnci_djv077 crossref_primary_10_1016_j_jid_2021_03_036 crossref_primary_10_3390_cancers11091220 crossref_primary_10_1134_S000629791206003X crossref_primary_10_1371_journal_pone_0085528 crossref_primary_10_1038_onc_2012_249 crossref_primary_10_1007_s12672_023_00855_4 crossref_primary_10_1016_j_cellsig_2018_03_010 crossref_primary_10_1155_2022_5498743 crossref_primary_10_1186_s13000_020_00947_7 crossref_primary_10_7717_peerj_6301 |
Cites_doi | 10.1038/35060032 10.1158/1078-0432.CCR-08-0124 10.1006/excr.1994.1063 10.1038/sj.emboj.7601886 10.1016/S0960-9822(99)80265-6 10.1038/sj.cdd.4400706 10.1016/0092-8674(94)90379-4 10.1158/1078-0432.CCR-03-0527 10.1038/sj.onc.1205276 10.1073/pnas.181181198 10.1074/jbc.M109062200 10.4161/cc.1.4.138 10.1158/0008-5472.CAN-05-0189 10.1038/ncb1101-973 10.1038/sj.onc.1202148 10.1128/MCB.21.6.2203-2212.2001 10.1128/MCB.19.5.3842 10.1016/0092-8674(88)90184-5 10.1038/35060148 10.1016/S0092-8674(00)80405-5 10.1073/pnas.94.26.14590 10.1016/S0968-0004(02)02113-8 10.1038/366707a0 10.1016/S0304-3835(01)00847-3 10.1093/emboj/18.5.1223 10.1016/S0929-6646(09)60051-6 10.1038/sj.onc.1209432 |
ContentType | Journal Article |
Copyright | 2010 Elsevier Inc. Copyright © 2010 Elsevier Inc. All rights reserved. 2010 Elsevier Inc. All rights reserved. 2010 |
Copyright_xml | – notice: 2010 Elsevier Inc. – notice: Copyright © 2010 Elsevier Inc. All rights reserved. – notice: 2010 Elsevier Inc. All rights reserved. 2010 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7TO H94 5PM |
DOI | 10.1016/j.bbrc.2010.10.126 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic Oncogenes and Growth Factors Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitleList | MEDLINE - Academic Oncogenes and Growth Factors Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry Biology |
EISSN | 1090-2104 |
EndPage | 107 |
ExternalDocumentID | PMC3001223 21040707 10_1016_j_bbrc_2010_10_126 S0006291X10020152 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R01 CA109311 – fundername: NCI NIH HHS grantid: P50 CA098258 – fundername: NCI NIH HHS grantid: CA16672 – fundername: NCI NIH HHS grantid: P30 CA016672 – fundername: NCI NIH HHS grantid: P01 CA099031 |
GroupedDBID | --- --K --M -~X .~1 0R~ 1B1 1RT 1~. 1~5 23N 4.4 457 4G. 53G 5GY 5VS 6J9 7-5 71M 8P~ 9JM 9M8 AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADIYS ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFFNX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC CS3 D0L DM4 DOVZS EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q HZ~ IHE J1W K-O KOM L7B LG5 LX2 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 RIG RNS ROL RPZ SCC SDF SDG SDP SES SPCBC SSU SSZ T5K TWZ WH7 XPP XSW ZA5 ZMT ~02 ~G- .55 .GJ .HR 1CY 3O- AAHBH AAQXK AATTM AAXKI AAYJJ AAYWO AAYXX ABDPE ABEFU ABWVN ACKIV ACRPL ACVFH ADCNI ADFGL ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRDE AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CAG CITATION COF FEDTE FGOYB G-2 GBLVA HLW HVGLF MVM OHT R2- SBG SEW SSH UQL WUQ X7M Y6R ZGI ZKB ~KM CGR CUY CVF ECM EFKBS EIF NPM 7X8 7TO H94 5PM |
ID | FETCH-LOGICAL-c508t-ab35238cefccb3e0ee5eaa2cfc1feff4df04c5cc8d2c4c26f9324bb721c8ef6f3 |
IEDL.DBID | .~1 |
ISSN | 0006-291X 1090-2104 |
IngestDate | Thu Aug 21 18:07:59 EDT 2025 Sun Aug 24 03:47:51 EDT 2025 Mon Jul 21 10:31:33 EDT 2025 Mon Jul 21 06:04:10 EDT 2025 Thu Apr 24 23:02:28 EDT 2025 Tue Jul 01 04:24:12 EDT 2025 Fri Feb 23 02:34:28 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | p21 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2010 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c508t-ab35238cefccb3e0ee5eaa2cfc1feff4df04c5cc8d2c4c26f9324bb721c8ef6f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 21040707 |
PQID | 816386026 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3001223 proquest_miscellaneous_907155268 proquest_miscellaneous_816386026 pubmed_primary_21040707 crossref_citationtrail_10_1016_j_bbrc_2010_10_126 crossref_primary_10_1016_j_bbrc_2010_10_126 elsevier_sciencedirect_doi_10_1016_j_bbrc_2010_10_126 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-12-03 |
PublicationDateYYYYMMDD | 2010-12-03 |
PublicationDate_xml | – month: 12 year: 2010 text: 2010-12-03 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Biochemical and biophysical research communications |
PublicationTitleAlternate | Biochem Biophys Res Commun |
PublicationYear | 2010 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Hutchinson, Jin, Cardiff, Woodgett, Muller (b0015) 2001; 21 Zhou, Liao, Xia, Spohn, Lee, Hung (b0055) 2001; 3 Suzuki, Kawano, Hayashida, Hayasaki, Tsutomi, Akahane (b0085) 2000; 7 Kane, Shapiro, Stokoe, Weiss (b0020) 1999; 9 Rahmani, Grant (b0105) 2002; 1 Dulic, Kaufmann, Wilson, Tlsty, Lees, Harper, Elledge, Reed (b0070) 1994; 76 Kumar, Hung (b0010) 2005; 65 Suzuki, Tsutomi, Yamamoto, Shibutani, Akahane (b0080) 1999; 19 Mayo, Donner (b0045) 2001; 98 Datta, Dudek, Tao, Masters, Fu, Gotoh, Greenberg (b0025) 1997; 91 Ashcroft, Ludwig, Woods, Copeland, Weber, MacRae, Vousden (b0040) 2002; 21 Burgering, Kops (b0030) 2002; 27 Li, Dowbenko, Lasky (b0095) 2002; 277 Muller, Sinn, Pattengale, Wallace, Leder (b0120) 1988; 54 De la Cueva, Garcia-Cao, Herranz, Lopez, Garcia-Palencia, Flores, Serrano, Fernandez-Piqueras, Martin-Caballero (b0125) 2006; 25 Xia, Chen, Zhou, Sun, Lee, Liao, Zhou, Hung (b0110) 2004; 10 Noda, Ning, Venable, Pereira-Smith, Smith (b0065) 1994; 211 Liu, Yeh, Zhu, Leversha, Cordon-Cardo, Ghossein, Singh, Holland, Koff (b0135) 2007; 26 Zhou, Liao, Xia, Zou, Spohn, Hung (b0050) 2001; 3 Roninson (b0075) 2002; 179 Huang, Hung (b0005) 2009; 108 Gu, Turck, Morgan (b0060) 1993; 366 El-Deiry (b0100) 2001; 3 Yang, Hung (b0035) 2009; 15 Deng, Xia, Hung (b0115) 1998; 17 Wang, Elson, Leder (b0130) 1997; 94 Asada, Yamada, Ichijo, Delia, Miyazono, Fukumuro, Mizutani (b0090) 1999; 18 Kane (10.1016/j.bbrc.2010.10.126_b0020) 1999; 9 Hutchinson (10.1016/j.bbrc.2010.10.126_b0015) 2001; 21 Suzuki (10.1016/j.bbrc.2010.10.126_b0080) 1999; 19 Gu (10.1016/j.bbrc.2010.10.126_b0060) 1993; 366 Deng (10.1016/j.bbrc.2010.10.126_b0115) 1998; 17 Liu (10.1016/j.bbrc.2010.10.126_b0135) 2007; 26 Datta (10.1016/j.bbrc.2010.10.126_b0025) 1997; 91 Mayo (10.1016/j.bbrc.2010.10.126_b0045) 2001; 98 De la Cueva (10.1016/j.bbrc.2010.10.126_b0125) 2006; 25 Zhou (10.1016/j.bbrc.2010.10.126_b0055) 2001; 3 Muller (10.1016/j.bbrc.2010.10.126_b0120) 1988; 54 Zhou (10.1016/j.bbrc.2010.10.126_b0050) 2001; 3 Noda (10.1016/j.bbrc.2010.10.126_b0065) 1994; 211 Wang (10.1016/j.bbrc.2010.10.126_b0130) 1997; 94 Burgering (10.1016/j.bbrc.2010.10.126_b0030) 2002; 27 Rahmani (10.1016/j.bbrc.2010.10.126_b0105) 2002; 1 Suzuki (10.1016/j.bbrc.2010.10.126_b0085) 2000; 7 Xia (10.1016/j.bbrc.2010.10.126_b0110) 2004; 10 Huang (10.1016/j.bbrc.2010.10.126_b0005) 2009; 108 Roninson (10.1016/j.bbrc.2010.10.126_b0075) 2002; 179 Li (10.1016/j.bbrc.2010.10.126_b0095) 2002; 277 Asada (10.1016/j.bbrc.2010.10.126_b0090) 1999; 18 El-Deiry (10.1016/j.bbrc.2010.10.126_b0100) 2001; 3 Ashcroft (10.1016/j.bbrc.2010.10.126_b0040) 2002; 21 Dulic (10.1016/j.bbrc.2010.10.126_b0070) 1994; 76 Yang (10.1016/j.bbrc.2010.10.126_b0035) 2009; 15 Kumar (10.1016/j.bbrc.2010.10.126_b0010) 2005; 65 |
References_xml | – volume: 7 start-page: 721 year: 2000 end-page: 728 ident: b0085 article-title: Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A publication-title: Cell Death Differ. – volume: 211 start-page: 90 year: 1994 end-page: 98 ident: b0065 article-title: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen publication-title: Exp. Cell Res. – volume: 3 start-page: E71 year: 2001 end-page: E73 ident: b0100 article-title: Akt takes centre stage in cell-cycle deregulation publication-title: Nat. Cell Biol. – volume: 94 start-page: 14590 year: 1997 end-page: 14595 ident: b0130 article-title: Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice publication-title: Proc. Natl. Acad. Sci. USA – volume: 27 start-page: 352 year: 2002 end-page: 360 ident: b0030 article-title: Cell cycle and death control: long live Forkheads publication-title: Trends Biochem. Sci. – volume: 76 start-page: 1013 year: 1994 end-page: 1023 ident: b0070 article-title: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest publication-title: Cell – volume: 17 start-page: 2167 year: 1998 end-page: 2175 ident: b0115 article-title: Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo publication-title: Oncogene – volume: 179 start-page: 1 year: 2002 end-page: 14 ident: b0075 article-title: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts publication-title: Cancer Lett. – volume: 3 start-page: 973 year: 2001 end-page: 982 ident: b0050 article-title: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation publication-title: Nat. Cell Biol. – volume: 65 start-page: 2511 year: 2005 end-page: 2515 ident: b0010 article-title: Signaling intricacies take center stage in cancer cells publication-title: Cancer Res. – volume: 98 start-page: 11598 year: 2001 end-page: 11603 ident: b0045 article-title: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus publication-title: Proc. Natl. Acad. Sci. USA – volume: 18 start-page: 1223 year: 1999 end-page: 1234 ident: b0090 article-title: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation publication-title: EMBO J. – volume: 25 start-page: 4128 year: 2006 end-page: 4132 ident: b0125 article-title: Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma publication-title: Oncogene – volume: 3 start-page: 245 year: 2001 end-page: 252 ident: b0055 article-title: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells publication-title: Nat. Cell Biol. – volume: 1 start-page: 273 year: 2002 end-page: 281 ident: b0105 article-title: UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937) publication-title: Cell Cycle – volume: 366 start-page: 707 year: 1993 end-page: 710 ident: b0060 article-title: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit publication-title: Nature – volume: 15 start-page: 752 year: 2009 end-page: 757 ident: b0035 article-title: A new fork for clinical application: targeting forkhead transcription factors in cancer publication-title: Clin. Cancer Res. – volume: 21 start-page: 1955 year: 2002 end-page: 1962 ident: b0040 article-title: Phosphorylation of HDM2 by Akt publication-title: Oncogene – volume: 91 start-page: 231 year: 1997 end-page: 241 ident: b0025 article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery publication-title: Cell – volume: 10 start-page: 3815 year: 2004 end-page: 3824 ident: b0110 article-title: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients publication-title: Clin. Cancer Res. – volume: 9 start-page: 601 year: 1999 end-page: 604 ident: b0020 article-title: Induction of NF-kappaB by the Akt/PKB kinase publication-title: Curr. Biol. – volume: 54 start-page: 105 year: 1988 end-page: 115 ident: b0120 article-title: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene publication-title: Cell – volume: 19 start-page: 3842 year: 1999 end-page: 3847 ident: b0080 article-title: Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death publication-title: Mol. Cell. Biol. – volume: 21 start-page: 2203 year: 2001 end-page: 2212 ident: b0015 article-title: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression publication-title: Mol. Cell. Biol. – volume: 26 start-page: 4683 year: 2007 end-page: 4693 ident: b0135 article-title: Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1) publication-title: EMBO J. – volume: 108 start-page: 180 year: 2009 end-page: 194 ident: b0005 article-title: Induction of Akt activity by chemotherapy confers acquired resistance publication-title: J. Formos. Med. Assoc. – volume: 277 start-page: 11352 year: 2002 end-page: 11361 ident: b0095 article-title: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival publication-title: J. Biol. Chem. – volume: 3 start-page: 245 year: 2001 ident: 10.1016/j.bbrc.2010.10.126_b0055 article-title: Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells publication-title: Nat. Cell Biol. doi: 10.1038/35060032 – volume: 15 start-page: 752 year: 2009 ident: 10.1016/j.bbrc.2010.10.126_b0035 article-title: A new fork for clinical application: targeting forkhead transcription factors in cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-08-0124 – volume: 211 start-page: 90 year: 1994 ident: 10.1016/j.bbrc.2010.10.126_b0065 article-title: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen publication-title: Exp. Cell Res. doi: 10.1006/excr.1994.1063 – volume: 26 start-page: 4683 year: 2007 ident: 10.1016/j.bbrc.2010.10.126_b0135 article-title: Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1) publication-title: EMBO J. doi: 10.1038/sj.emboj.7601886 – volume: 9 start-page: 601 year: 1999 ident: 10.1016/j.bbrc.2010.10.126_b0020 article-title: Induction of NF-kappaB by the Akt/PKB kinase publication-title: Curr. Biol. doi: 10.1016/S0960-9822(99)80265-6 – volume: 7 start-page: 721 year: 2000 ident: 10.1016/j.bbrc.2010.10.126_b0085 article-title: Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4400706 – volume: 76 start-page: 1013 year: 1994 ident: 10.1016/j.bbrc.2010.10.126_b0070 article-title: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest publication-title: Cell doi: 10.1016/0092-8674(94)90379-4 – volume: 10 start-page: 3815 year: 2004 ident: 10.1016/j.bbrc.2010.10.126_b0110 article-title: Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-03-0527 – volume: 21 start-page: 1955 year: 2002 ident: 10.1016/j.bbrc.2010.10.126_b0040 article-title: Phosphorylation of HDM2 by Akt publication-title: Oncogene doi: 10.1038/sj.onc.1205276 – volume: 98 start-page: 11598 year: 2001 ident: 10.1016/j.bbrc.2010.10.126_b0045 article-title: A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.181181198 – volume: 277 start-page: 11352 year: 2002 ident: 10.1016/j.bbrc.2010.10.126_b0095 article-title: AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival publication-title: J. Biol. Chem. doi: 10.1074/jbc.M109062200 – volume: 1 start-page: 273 year: 2002 ident: 10.1016/j.bbrc.2010.10.126_b0105 article-title: UCN-01 (7-hydroxystauorsporine) blocks PMA-induced maturation and reciprocally promotes apoptosis in human myelomonocytic leukemia cells (U937) publication-title: Cell Cycle doi: 10.4161/cc.1.4.138 – volume: 65 start-page: 2511 year: 2005 ident: 10.1016/j.bbrc.2010.10.126_b0010 article-title: Signaling intricacies take center stage in cancer cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-0189 – volume: 3 start-page: 973 year: 2001 ident: 10.1016/j.bbrc.2010.10.126_b0050 article-title: HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation publication-title: Nat. Cell Biol. doi: 10.1038/ncb1101-973 – volume: 17 start-page: 2167 year: 1998 ident: 10.1016/j.bbrc.2010.10.126_b0115 article-title: Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo publication-title: Oncogene doi: 10.1038/sj.onc.1202148 – volume: 21 start-page: 2203 year: 2001 ident: 10.1016/j.bbrc.2010.10.126_b0015 article-title: Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.21.6.2203-2212.2001 – volume: 19 start-page: 3842 year: 1999 ident: 10.1016/j.bbrc.2010.10.126_b0080 article-title: Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death publication-title: Mol. Cell. Biol. doi: 10.1128/MCB.19.5.3842 – volume: 54 start-page: 105 year: 1988 ident: 10.1016/j.bbrc.2010.10.126_b0120 article-title: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene publication-title: Cell doi: 10.1016/0092-8674(88)90184-5 – volume: 3 start-page: E71 year: 2001 ident: 10.1016/j.bbrc.2010.10.126_b0100 article-title: Akt takes centre stage in cell-cycle deregulation publication-title: Nat. Cell Biol. doi: 10.1038/35060148 – volume: 91 start-page: 231 year: 1997 ident: 10.1016/j.bbrc.2010.10.126_b0025 article-title: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery publication-title: Cell doi: 10.1016/S0092-8674(00)80405-5 – volume: 94 start-page: 14590 year: 1997 ident: 10.1016/j.bbrc.2010.10.126_b0130 article-title: Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.94.26.14590 – volume: 27 start-page: 352 year: 2002 ident: 10.1016/j.bbrc.2010.10.126_b0030 article-title: Cell cycle and death control: long live Forkheads publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(02)02113-8 – volume: 366 start-page: 707 year: 1993 ident: 10.1016/j.bbrc.2010.10.126_b0060 article-title: Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit publication-title: Nature doi: 10.1038/366707a0 – volume: 179 start-page: 1 year: 2002 ident: 10.1016/j.bbrc.2010.10.126_b0075 article-title: Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts publication-title: Cancer Lett. doi: 10.1016/S0304-3835(01)00847-3 – volume: 18 start-page: 1223 year: 1999 ident: 10.1016/j.bbrc.2010.10.126_b0090 article-title: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation publication-title: EMBO J. doi: 10.1093/emboj/18.5.1223 – volume: 108 start-page: 180 year: 2009 ident: 10.1016/j.bbrc.2010.10.126_b0005 article-title: Induction of Akt activity by chemotherapy confers acquired resistance publication-title: J. Formos. Med. Assoc. doi: 10.1016/S0929-6646(09)60051-6 – volume: 25 start-page: 4128 year: 2006 ident: 10.1016/j.bbrc.2010.10.126_b0125 article-title: Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma publication-title: Oncogene doi: 10.1038/sj.onc.1209432 |
SSID | ssj0011469 |
Score | 2.1435614 |
Snippet | ► Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. ► Akt-activated p21 accelerated tumor onset in MMTV/neu mice. ►... While p21 is well known to inhibit cyclin-CDK activity in the nucleus and it has also been demonstrated to have oncogenic properties in different types of... a-[ordm Akt-activated p21 was primarily expressed in cytoplasm of cells in transgenic mice. a-[ordm Akt-activated p21 accelerated tumor onset in MMTV/neu mice.... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 103 |
SubjectTerms | Animals Breast Neoplasms - metabolism Breast Neoplasms - pathology Cell Transformation, Neoplastic - metabolism Cell Transformation, Neoplastic - pathology Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis Epithelium - metabolism Epithelium - pathology Female Humans Lung metastasis Lung Neoplasms - metabolism Lung Neoplasms - secondary Mammary Neoplasms, Experimental - metabolism Mammary Neoplasms, Experimental - pathology Mammary tumorigenesis Mice Mice, Transgenic Mouse mammary tumor virus p21 PKB/Akt Proto-Oncogene Proteins c-akt - metabolism |
Title | Activation of p21(CIP1/WAF1) in mammary epithelium accelerates mammary tumorigenesis and promotes lung metastasis |
URI | https://dx.doi.org/10.1016/j.bbrc.2010.10.126 https://www.ncbi.nlm.nih.gov/pubmed/21040707 https://www.proquest.com/docview/816386026 https://www.proquest.com/docview/907155268 https://pubmed.ncbi.nlm.nih.gov/PMC3001223 |
Volume | 403 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5VRQguCFoeaUu1B4RAKMSP9cY-mogoBVFxoCI3a5-qUeyYxjn00t_embXXIqD2wM3yzsqOZzzzTTzzDSFvYshJEglJTqgzDgmKTsdCwnulpY4lT6YicbSL38754oJ9WSbLPTLzvTBYVtn7_s6nO2_dn5n0T3PSlCX2-AY8ysIlkohCUEM_zNgUrfzjzVDmgU23PQTmY5TuG2e6Gi8pr1RX3uV4Fvhdwelf8Pl3DeUfQWn-lDzp0STNuxt-RvZMfUAO8xoy6eqavqWuvtP9cX5AHn7yR49mfsrbIfmdKz_gjK4tbaLw3ezsezj5mc_D97SsaSVcdxs1DXZvrMptRYVSEKyQY2IzLLfbCmdsoecsN1TUmjau0A9EVuBPaGVaAUAUFp-Ti_nnH7PFuB_DMFaA3lrUHWSrqTJWKRmbwJjECBEpq0JrrGXaBkwlSqU6UkxF3AIkZFJCaqlSY7mNX5D9el2bV4SKVEx1JnWQCcPiwKRwAeSLz3gG0IvxEQn98y9Uz1GOozJWhS9G-1WgzgrUmTsXwZ4Pw56mY-i4Vzrxai127KyAEHLvPuptoAAN4VcVUZv1dlOkiGhxkNfdIhnguAR5dUbkZWc1w51Cxs2QcWlEpjv2NAgg_ffuSl1eOhrw2H0WjY_-8xcdk8eRL82JT8h-e7U1rwFgtfLUvUGn5EF-9nVxfgtYYyc7 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRWi5INjlUZ4-AAKh0sRJ3OTAoRSqln2Iw67oLWs7tghq0rBNhfbCn-IPMuPEEQXtHpD2VsV26njseSTffEPI8wBikkhCkONnCYcAJYv7QsK5ymQWSB4NRWRpFw-P-PQk_DSP5lvkl8uFQVhlq_sbnW61dXtl0K7moMpzzPH1OEv8OZKIglFjLbJyX5__gLht9W72AYT8grHJx-PxtN-WFugr8EhqnA9EYLHSRikZaE_rSAvBlFG-0caEmfFCFSkVZ0yFinEDbk4oJYRLKtaGmwDue41cD0FdYNmEtz87XAlm-bY-N-_j9NpMnQZUJuWZavBkltiBX2QN__V2_wZt_mEFJ7fJrdZ9paNmhe6QLV3ukr1RCaF7cU5fUgsotW_qd8mN9-7XztiVldsj30fKVVSjS0Mr5r8azz77gy-jif-a5iUthE2no7rCdJFFvi6oUAqsI5JarLrmel1gUS9U1fmKijKjlUUWQpcFKDBa6FqA5wuNd8nJlQjnHtkul6V-QKiIxTBLZOYlQoeBp2P4AySoT3gCvl7Ie8R365-qlhQda3MsUod--5aizFKUmb3GYMybbkzVUIJc2jtyYk03NnYKNuvScdTtgRQkhJ9xRKmX61UaowuNlcMu7pKA4xghkU-P3G92TTdTCPFDpHjqkeHGfuo6IN_4ZkuZf7W844H9Dhs8_M8nekZ2pseHB-nB7Gj_EbnJHC4oeEy267O1fgLeXS2f2tNEyelVH9_feNNnDQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Activation+of+p21%28CIP1%2FWAF1%29+in+Mammary+Epithelium+Accelerates+Mammary+Tumorigenesis+and+Promotes+Lung+Metastasis&rft.jtitle=Biochemical+and+biophysical+research+communications&rft.au=Cheng%2C+Xiaoyun&rft.au=Xia%2C+Weiya&rft.au=Yang%2C+Jer-Yen&rft.au=Hsu%2C+Jennifer+L.&rft.date=2010-12-03&rft.issn=0006-291X&rft.eissn=1090-2104&rft.volume=403&rft.issue=1&rft.spage=103&rft.epage=107&rft_id=info:doi/10.1016%2Fj.bbrc.2010.10.126&rft_id=info%3Apmid%2F21040707&rft.externalDocID=PMC3001223 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-291X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-291X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-291X&client=summon |